1-3 of 3
Victoria Wang, PhD
Close
Sort by
Journal Articles

A Phase I Dose Finding Trial of Eltrombopag during Consolidation Therapy in Adults with Acute Myeloid Leukemia Employing a Unique Dosing Design: PrE0901, a Precog Study

Stephen A. Strickland, Hillard M. Lazarus, MD, Xin Victoria Wang, PhD, Jan Cerny, MD PhD, Witold B. Rybka, MD, Martin S. Tallman, MD, Mark R. Litzow, MD
Journal: Blood
Blood (2016) 128 (22): 4053.
https://doi.org/10.1182/blood.V128.22.4053.4053
Published: 2016
Journal Articles

A Randomized Phase II Trial of Three Novel Regimens for Relapsed/ Refractory Acute Myeloid Leukemia (AML) Demonstrates Encouraging Results with a Flavopiridol-Based Regimen: Results of Eastern Cooperative Oncology Group (ECOG) Trial E1906

Mark R. Litzow, MD, Xin Victoria Wang, PhD, Martin P. Carroll, MD, Judith E. Karp, MD, Rhett Ketterling, MD, Scott H. Kaufmann, MD PhD, Hillard M. Lazarus, Selina M. Luger, MD, Elisabeth M. Paietta, PhD, Jacob M. Rowe, MD, Jessica K Altman, Keith W Pratz, MD, E. Randolph Broun, MD, Martin S. Tallman, MD
Journal: Blood
Blood (2014) 124 (21): 3742.
https://doi.org/10.1182/blood.V124.21.3742.3742
Published: 2014
Journal Articles

Distinct Human and Viral Interleukin-6 Profiles and Other Viral and Immunologic Abnormalities In KSHV-Associated Multicentric Castleman Disease: Relationship with Disease Activity and Individual Disease Manifestations

Mark N Polizzotto, MBBS, BMedSc, Thomas S Uldrick, MD, MS, Victoria Wang, PhD, Karen Aleman, RN, Kathleen M Wyvill, RN, Vickie Marshall, PhD, Stefania Pittaluga, MD, PhD, Deirdre O'Mahony, MBBS, Denise Whitby, PhD, Giovanna Tosato, PhD, Seth M. Steinberg, PhD, Richard F Little, MD, MPH, Robert Yarchoan, MD
Journal: Blood
Blood (2011) 118 (21): 1573.
https://doi.org/10.1182/blood.V118.21.1573.1573
Published: 2011